Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-169472
Filing Date
2014-04-30
Accepted
2014-04-30 09:21:41
Documents
15
Period of Report
2014-06-12
Effectiveness Date
2014-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d676958ddef14a.htm DEF 14A 1130468
3 GRAPHIC g676958g01i79.jpg GRAPHIC 27856
4 GRAPHIC g676958g01l39.jpg GRAPHIC 29056
5 GRAPHIC g676958g07e46.jpg GRAPHIC 6311
6 GRAPHIC g676958g10l20.jpg GRAPHIC 19646
7 GRAPHIC g676958g13q11.jpg GRAPHIC 1874
8 GRAPHIC g676958g24b42.jpg GRAPHIC 9728
9 GRAPHIC g676958g29q54.jpg GRAPHIC 2033
10 GRAPHIC g676958g33t56.jpg GRAPHIC 18416
11 GRAPHIC g676958g98j05.jpg GRAPHIC 4961
12 GRAPHIC g676958pc1a.jpg GRAPHIC 39323
13 GRAPHIC g676958pc1b.jpg GRAPHIC 44997
14 GRAPHIC g676958pc1c.jpg GRAPHIC 3973
15 GRAPHIC g676958pc1d.jpg GRAPHIC 17289
16 GRAPHIC g676958pc1e.jpg GRAPHIC 37794
  Complete submission text file 0001193125-14-169472.txt   1496473
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN IDEC INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-19311 | Film No.: 14796146
SIC: 2836 Biological Products, (No Diagnostic Substances)